Risk factors of post-intubation hypotension in severe pneumonia patients

Post-intubation hypotension (PIH) was one of the serious complications after Endotracheal intubation (ETI) in Severe pneumonia (SP) patients. The risk factors of PIH were investigated in SP patients to provide a theoretical basis of early intervention. This was a retrospective study wherein 420 SP patients undergone ETI from December 2019 to December 2022 were selected as the study subjects. Patients were divided into the hypotension and normal blood pressure groups based on the blood pressures recorded after intubation. Two groups were compared for the general data and various physicochemical indicators before the intubation. The independent risk factors of hypotension after tracheal intubation were explored in SP patients through univariate and multivariate logistic regression. PIH was developed in 170 (40.47%) SP patients. Univariate logistic regression analysis exhibited that age (Odd Ratio (OR) = 1.021, p = 0.001), weight (OR = 0.976, p = 0.015), inducer usage before intubation (OR = 1.221, p < 0.001), chronic obstructive pulmonary disease (OR = 1.768, p = 0.013), sepsis (OR = 1.870, p = 0.006), and hyperelastic acidemia (OR = 1.665, p = 0.012) were associated with PIH. Multivariate logistic regression analysis indicated that age (OR = 1.015, p = 0.033), weight (OR = 0.974, p = 0.012), inducer usage before intubation (OR = 1.228, p < 0.001), chronic obstructive pulmonary disease (OR = 1.660, p = 0.037), sepsis (OR = 1.733, p = 0.035), and hyperelastic acidemia (OR = 1.679, p = 0.018) were the independent risk factors of PIH. The study demonstrated that SP patients were prone to PIH with advanced age, low body weight, inducer usage before intubation, increased lactic acid levels before intubation, and high risk factors of chronic obstructive pulmonary disease (COPD) or sepsis. The findings had potential of advanced patient care, and refined medical practices, and could stimulate further investigations in the field.

Severe pneumonia; Endotracheal intubation; Hypotension; Risk factors

[1] Martin-Loeches I, Torres A. New guidelines for severe community-acquired pneumonia. Current Opinion in Pulmonary Medicine. 2021; 27: 210–215.

[2] Hernández G, Paredes I, Moran F, Buj M, Colinas L, Rodríguez ML, et al. Effect of postextubation noninvasive ventilation with active humidification vs high-flow nasal cannula on reintubation in patients at very high risk for extubation failure: a randomized trial. Intensive Care Medicine. 2022; 48: 1751–1759.

[3] Lascarrou JB, Boisrame-Helms J, Bailly A, Le Thuaut A, Kamel T, Mercier E, et al. Video laryngoscopy vs direct laryngoscopy on successful first-pass orotracheal intubation among ICU patients. JAMA. 2017; 317: 483.

[4] De Jong A, Myatra SN, Roca O, Jaber S. How to improve intubation in the intensive care unit. Update on knowledge and devices. Intensive Care Medicine. 2022; 48: 1287–1298.

[5] Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock. Intensive Care Medicine. 2021; 47: 1181–1247.

[6] Althunayyan SM. Shock index as a predictor of post interbation hypotension and cardiac arrest: a review of the current evidence. Bulletin of Emergency and Trauma. 2019; 7: 21–27.

[7] Russell DW, Casey JD, Gibbs KW, Ghamande S, Dargin JM, Vonderhaar DJ, et al. Effect of fluid bolus administration on cardiovascular collapse among critically ill patients undergoing tracheal intubation: a randomized clinical trial. JAMA. 2022; 328: 270–279.

[8] Nab L, Parker EPK, Andrews CD, Hulme WJ, Fisher L, Morley J, et al. Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022: a retrospective cohort study using the OpenSAFELY platform. The Lancet Public Health. 2023; 8: e364–e377.

[9] Brodsky MB, Akst LM, Jedlanek E, Pandian V, Blackford B, Price C, et al. Laryngeal injury and upper airway symptoms after endotracheal intubation during surgery: a systematic review and meta-analysis. Anesthesia & Analgesia. 2021; 132: 1023–1032.

[10] Akar-Ghibril N. Defects of the innate immune system and related immune deficiencies. Clinical Reviews in Allergy & Immunology. 2022; 63: 36–54.

[11] Lin Y. The Src-ZNRF1 axis controls TLR3 trafficking and interferon responses to limit lung barrier damage. Journal of Experimental Medicine. 2023; 220: e20220727.

[12] Gaujoux S, Partelli S, Maire F, D’Onofrio M, Larroque B, Tamburrino D, et al. Observational study of natural history of small sporadic nonfunctioning pancreatic neuroendocrine tumors. The Journal of Clinical Endocrinology & Metabolism. 2013; 98: 4784–4789.

[13] Finkelstein P, Sharma R, Picado O, Gadde R, Stuart H, Ripat C, et al. Pancreatic neuroendocrine tumors (panNETs): analysis of overall survival of nonsurgical management versus surgical resection. Journal of Gastrointestinal Surgery. 2017; 21: 855–866.

[14] Scott AT, Howe JR. Evaluation and management of neuroendocrine tumors of the pancreas. Surgical Clinics of North America. 2019; 99: 793–814.

[15] Liu G, Liu Q, Wan N, Shen X, Cui H, Dong C, et al. Cardioprotection by peroxidase activity of prostaglandin H synthases in ischemia/reperfusion injury. Circulation. 2023; 147: 1467–1470.

[16] Teong CY, Huang CC, Sun FJ. The haemodynamic response to endotracheal intubation at different time of fentanyl given during induction: a randomised controlled trial. Scientific Reports. 2020; 10: 8829.

[17] Green RS, Edwards J, Sabri E, Fergusson D. Evaluation of the incidence, risk factors, and impact on patient outcomes of postintubation hemodynamic instability. Canadian Journal of Emergency Medicine. 2012; 14: 74–82.

[18] Andersen LW, Mackenhauer J, Roberts JC, Berg KM, Cocchi MN, Donnino MW. Etiology and therapeutic approach to elevated lactate levels. Mayo Clinic Proceedings. 2013; 88: 1127–1140.

[19] Brooks GA. The science and translation of lactate shuttle theory. Cell Metabolism. 2018; 27: 757–785.

[20] Yang L, Xie X, Tu Z, Fu J, Xu D, Zhou Y. The signal pathways and treatment of cytokine storm in COVID-19. Signal Transduction and Targeted Therapy. 2021; 6: 255.

[21] Caslin HL, Abebayehu D, Pinette JA, Ryan JJ. Lactate is a metabolic mediator that shapes immune cell fate and function. Frontiers in Physiology. 2021; 12: 688485.

[22] Vandewalle J, Timmermans S, Paakinaho V, Vancraeynest L, Dewyse L, Vanderhaeghen T, et al. Combined glucocorticoid resistance and hyperlactatemia contributes to lethal shock in sepsis. Cell Metabolism. 2021; 33: 1763–1776.e5.

[23] Wright SW, Hantrakun V, Rudd KE, Lau C, Lie KC, Chau NVV, et al. Enhanced bedside mortality prediction combining point-of-care lactate and the quick Sequential Organ Failure Assessment (qSOFA) score in patients hospitalised with suspected infection in southeast Asia: a cohort study. The Lancet Global Health. 2022; 10: e1281–e1288.

[24] Bartos JA, Grunau B, Carlson C, Duval S, Ripeckyj A, Kalra R, et al. Improved survival with extracorporeal cardiopulmonary resuscitation despite progressive metabolic derangement associated with prolonged resuscitation. Circulation. 2020; 141: 877–886.

[25] Lauder L, Mahfoud F, Azizi M, Bhatt DL, Ewen S, Kario K, et al. Hypertension management in patients with cardiovascular comorbidities. European Heart Journal. 2023; 44: 2066–2077.

[26] Glickman SW, Cairns CB, Otero RM, Woods CW, Tsalik EL, Langley RJ, et al. Disease progression in hemodynamically stable patients presenting to the emergency department with sepsis. Academic Emergency Medicine. 2010; 17: 383–390.

[27] Bakker J, Nijsten MW, Jansen TC. Clinical use of lactate monitoring in critically ill patients. Annals of Intensive Care. 2013; 3: 12.

[28] Agarwal AK, Raja A, Brown BD. Chronic obstructive pulmonary disease. StatPearls Publishing: Treasure Island (FL). 2023.

[29] Jiang C, Chen Q, Xie M. Smoking increases the risk of infectious diseases: a narrative review. Tobacco Induced Diseases. 2020; 18: 60.

[30] Kupryś-Lipińska I, Kuna P. Impact of chronic obstructive pulmonary disease (COPD) on patient’s life and his family. Advances in Respiratory Medicine. 2014; 82: 82–95.

[31] Restrepo MI, Sibila O, Anzueto A. Pneumonia in patients with chronic obstructive pulmonary disease. Tuberculosis and Respiratory Diseases. 2018; 81: 187.